News for Healthier Living

Common Obesity Medications Lead to Higher Muscle Loss Than Other Weight Loss Interventions, Review Finds

A systematic review of clinical trials found that adults treated with incretin-based obesity medications, like semaglutide and tirzepatide, not only lose significant body fat but also tend to have more muscle-related loss than with other weight loss interventions.

April 17, 2026


April 17 2026

April 16 2026

April 15 2026

April 14 2026

April 13 2026

April 12 2026

April 11 2026

April 10 2026

April 9 2026

April 8 2026

April 7 2026

April 6 2026

April 5 2026

April 4 2026

April 3 2026